DAWES KAREN A bought RGEN
May 14, 2026 · Form 4 insider transaction
DAWES KAREN A bought 2,239 shares of Repligen Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,239
Price
$0.00
Total value
N/A
InsiderDAWES KAREN A
RoleDirector
CompanyRepligen Corporation (RGEN)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMay 14, 2026
Filing dateMay 18, 2026
Shares owned after2,239
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.